top of page
Search

Success or Failure? Managing a Portfolio of Stocks

  • Writer: Tim Morton, CFA
    Tim Morton, CFA
  • Jul 16, 2024
  • 2 min read

Nine months ago I designed the MIR20 strategy and invested in a portfolio of 20 stocks. Given the passage of time, what worked and what failed?


The MIR20 stock strategy has a defined set of stock selection metrics and risk-reducing rules as outlined in my post last fall. MIR20 - Significant Return Opportunities with Risk Controls


The rules were strict and discipline was maintained despite my wanting to overrule the risk controls (do you really want to sell a stock after it moves down 20%, surely it will recover...)


The results so far and a snapshot of the current portfolio:




The strategy's objective was to outperform its relevant benchmark (S&P 400 - Mid Cap Index, as reflected by the MDY ETF) by 20% per year, over a three-year time frame (i.e., the benchmark MDY advances 10% and MIR20 produces a 12% return). It's not an easy goal! Additionally, I want the strategy to experience a 20% reduction (versus the index) in loss of portfolio value during market selloffs.


As of July 16, 2024, the strategy has advanced 29.1% versus the benchmark return of 25.5% (the MIR20 strategy outperformed the benchmark by 14% over these nine months).


This return was achieved after hedging expenses. MIR20 has been purchasing portfolio S&P 500 put "insurance" over this time frame (MIR20 gross return 31.3% - 2.1% insurance expense = 29.1%). The cost of insurance has been relatively inexpensive, at a nine-month total cost of 2.1% (think of the MIR20 portfolio insurance as hurricane or flood insurance, it only begins to pay out significantly when we experience a 10% drop in the S&P 500 value).


There has not been a 10% correction in the major markets since establishing the strategy, so the goal of being 20% less volatile than the benchmark has not been ascertained. It will certainly be tested going forward.


Over the next few months, I will review the most important features of the strategy. What worked and what has disappointed... the Good, the Bad and the Ugly.


Some high-level thoughts to expand upon in the coming months.


  • Are the individual stock returns random?

  • Will the portfolio insurance activate as expected, when required?

  • Percentage winning versus losing trades and their respective returns. ...does this produce a superior return, relative to just owning an index?

  • Buying beaten-up stocks (Lululemon) versus stocks that are flying high (Crocs).... make a predictable difference?

  • Does the strategy Stop Loss rules protect capital?

  • Did extensive research on each potential purchase prove to be worthwhile?

  • The difficulty in finding undervalued stocks after a substantial rally (the situation I am encountering today).


For those with an interest, I will post ongoing MIR20 updates and analysis on Mortonir.com and invite you to periodically check the website for ongoing comments on MIR20. If you would like to receive a direct email on MIR20 comments please let me know.


regards, Tim




Tim Morton, CFA is a retired portfolio manager with 45 years of experience working with private clients. For the past two years, the editor of mortonir.com and a contributor to Barron's. My comments are not to be taken as investment recommendations. They are purely for discussion purposes. Please see your advisor for investment advice.




 
 
 

Comments


bottom of page